The FGF/FGF receptor axis as a therapeutic target in breast cancer
Author:
Publisher
Informa UK Limited
Subject
Endocrinology, Diabetes and Metabolism
Link
http://www.tandfonline.com/doi/pdf/10.1586/17446651.2013.811910
Reference94 articles.
1. Cellular signaling by fibroblast growth factor receptors
2. Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a Dual Role for Heparin in FGFR Binding and Dimerization
3. An Essential Heparin-Binding Domain in the Fibroblast Growth Factor Receptor Kinase
4. Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Genomic Landscape of Breast Cancer in Young and Older Women;Clinical Breast Cancer;2024-07
2. Chitosan Modification-Enhanced Silencing Effect of Ad5-shPDGF-D Vector in Breast Cancer Cell Line MDA-MB-231;Current Drug Delivery;2023-10
3. Reprogramming of glucose metabolism via PFKFB4 is critical in FGF16-driven invasion of breast cancer cells;Bioscience Reports;2023-08
4. Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms;Journal of Biological Chemistry;2023-08
5. XAI-CNVMarker: Explainable AI-based copy number variant biomarker discovery for breast cancer subtypes;Biomedical Signal Processing and Control;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3